-

The Law Offices of Frank R. Cruz Announces Investigation of GoHealth, Inc. (GOCO) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of GoHealth, Inc. (“GoHealth” or the “Company”) (NASDAQ: GOCO) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

In July 2020, GoHealth sold approximately 43.5 million shares of stock in its initial public stock offering (the "IPO"), at $21.00 per share raising almost $914 million in new capital.

Then, on August 19, 2020, in its first quarterly earnings report following the IPO, GoHealth announced that it incurred a net loss of $22.9 million after posting net income of $15.3 million in the prior-year period.

On this news, the Company's stock price fell $1.99 per share, or 10%, to close at $17.03 per share on August 20, 2020, thereby injuring investors.

On September 15, 2020, GoHealth’s stock price closed at $12.53, a 40% decline from its IPO price.

Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you purchased GoHealth securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

The Law Offices of Frank R. Cruz

NASDAQ:GOCO

Release Versions
$Cashtags

Contacts

The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com

More News From The Law Offices of Frank R. Cruz

Deadline Soon: MoonLake Immunotherapeutics (MLTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 15, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired MoonLake Immunotherapeutics ("MoonLake" or the Company") (NASDAQ: MLTX) securities between March 10, 2024 and September 29, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON MOONLAKE (MLTX), CLICK HERE TO PARTICIPATE IN THE...

Deadline Soon: Baxter International, Inc. (BAX) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming December 15, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX) securities between February 23, 2022 and October 29, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON BAXTER (BAX), CLICK HERE TO PARTICIPATE IN THE SECURIT...

Securities Fraud Investigation Into Fermi Inc. (FRMI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Fermi Inc. (“Fermi” or the “Company”) (NASDAQ: FRMI) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON FERMI (FRMI), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On October 1, 2025, Fermi began trading on the NASDAQ at $21.00 per share following its In...
Back to Newsroom